Patent · US Active

Kinase inhibitors

US7713973B2 · kind B2 · utility

15Cited by
44References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2005
Grant dateMay 11, 2010
Priority date
Expiry dateApr 19, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:wherein the variables are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.